Analyst Ratings for GT Biopharma Inc. (GTBP)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/5/2023 | EF Hutton | Tony Butler | New Coverage | Hold (N/A) |
2.00 (N/A) |
1.02 (3.75) |
267.65% | Details |
| 8/11/2022 | Roth/MKM | Tony Butler | Downgrade | Neutral (Buy) |
3.00 (9.00) |
2.87 (3.75) |
30.66% | Details |
 |
||||||||
|
||||||||
